Genprex is committed to pay Manhattan Street Capital these fees; Cash of $15k with the option to pay $30k in equity instead of cash. Warrants with face value of $30k priced at the average of the recent ...
RodTurners blogg Genprex is raising capital through their IPO ... Genprex has developed Oncoprex, a unique medicine that is delivered to lung ... system to attack the tumors. Genprex is raising $6.5 mill at a pre-money ...
RodTurner's blog Prospectus. Genprex is raising capital through ... Varner, CEO of Genprex, said, "Had I known the benefits of using Reg A ... treatment to the tumors effectively is a major challenge. Genprex har ...
RodTurner's blog Prospectus. Genprex has completed its S-1 IPO ... Capital has rights to warrants in Genprex, so we have a conflict ... to the tumors effectively is a major challenge. Genprex has developed a unique ...
RodTurners blogg Genprex (S-1 IPO) expects to list on the NASDAQ on Friday March 16 th- two days left. Their Oncoprex medicine ... cell death. Genprex is raising $6.5 mill at a pre-money valuation ...
Fullført S-1 IPO NASDAQ: GNPX Lungekreft Klinisk stadiumgenerapi
Underwriter; Network1 Financial Underwriter Advokat; Philip Magri Magri Law LLC, Ft. Lauderdale, FL Genprex Råd; Christopher J. Ozburn, Streusand Landon & Ozburn, LLP. Austin TX Transfer Agent; V lager ...
Privat tilbud for velstående investorer
